nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Infestation NOS—Methotrexate—multiple sclerosis	0.000838	0.000838	CcSEcCtD
Ibandronate—Infestation—Methotrexate—multiple sclerosis	0.000838	0.000838	CcSEcCtD
Ibandronate—Rash—Azathioprine—multiple sclerosis	0.000837	0.000837	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000837	0.000837	CcSEcCtD
Ibandronate—Dermatitis—Azathioprine—multiple sclerosis	0.000836	0.000836	CcSEcCtD
Ibandronate—Depression—Methotrexate—multiple sclerosis	0.000836	0.000836	CcSEcCtD
Ibandronate—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000835	0.000835	CcSEcCtD
Ibandronate—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000835	0.000835	CcSEcCtD
Ibandronate—Discomfort—Triamcinolone—multiple sclerosis	0.000834	0.000834	CcSEcCtD
Ibandronate—Discomfort—Methylprednisolone—multiple sclerosis	0.000832	0.000832	CcSEcCtD
Ibandronate—Headache—Azathioprine—multiple sclerosis	0.000831	0.000831	CcSEcCtD
Ibandronate—Dry mouth—Triamcinolone—multiple sclerosis	0.000826	0.000826	CcSEcCtD
Ibandronate—Renal failure—Methotrexate—multiple sclerosis	0.000824	0.000824	CcSEcCtD
Ibandronate—Angioedema—Betamethasone—multiple sclerosis	0.000822	0.000822	CcSEcCtD
Ibandronate—Angioedema—Dexamethasone—multiple sclerosis	0.000822	0.000822	CcSEcCtD
Ibandronate—Stomatitis—Methotrexate—multiple sclerosis	0.000817	0.000817	CcSEcCtD
Ibandronate—Angiopathy—Prednisone—multiple sclerosis	0.000817	0.000817	CcSEcCtD
Ibandronate—Immune system disorder—Prednisone—multiple sclerosis	0.000813	0.000813	CcSEcCtD
Ibandronate—Malaise—Betamethasone—multiple sclerosis	0.000812	0.000812	CcSEcCtD
Ibandronate—Malaise—Dexamethasone—multiple sclerosis	0.000812	0.000812	CcSEcCtD
Ibandronate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000809	0.000809	CcSEcCtD
Ibandronate—Vertigo—Betamethasone—multiple sclerosis	0.000809	0.000809	CcSEcCtD
Ibandronate—Vertigo—Dexamethasone—multiple sclerosis	0.000809	0.000809	CcSEcCtD
Ibandronate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000808	0.000808	CcSEcCtD
Ibandronate—Infection—Triamcinolone—multiple sclerosis	0.000804	0.000804	CcSEcCtD
Ibandronate—Sweating—Methotrexate—multiple sclerosis	0.000804	0.000804	CcSEcCtD
Ibandronate—Infection—Methylprednisolone—multiple sclerosis	0.000802	0.000802	CcSEcCtD
Ibandronate—Shock—Triamcinolone—multiple sclerosis	0.000796	0.000796	CcSEcCtD
Ibandronate—Insomnia—Prednisolone—multiple sclerosis	0.000796	0.000796	CcSEcCtD
Ibandronate—Alopecia—Prednisone—multiple sclerosis	0.000796	0.000796	CcSEcCtD
Ibandronate—Shock—Methylprednisolone—multiple sclerosis	0.000795	0.000795	CcSEcCtD
Ibandronate—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000793	0.000793	CcSEcCtD
Ibandronate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000792	0.000792	CcSEcCtD
Ibandronate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00079	0.00079	CcSEcCtD
Ibandronate—Paraesthesia—Prednisolone—multiple sclerosis	0.00079	0.00079	CcSEcCtD
Ibandronate—Mental disorder—Prednisone—multiple sclerosis	0.000789	0.000789	CcSEcCtD
Ibandronate—Nausea—Azathioprine—multiple sclerosis	0.000788	0.000788	CcSEcCtD
Ibandronate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000785	0.000785	CcSEcCtD
Ibandronate—Malnutrition—Prednisone—multiple sclerosis	0.000784	0.000784	CcSEcCtD
Ibandronate—Erythema—Prednisone—multiple sclerosis	0.000784	0.000784	CcSEcCtD
Ibandronate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000783	0.000783	CcSEcCtD
Ibandronate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000781	0.000781	CcSEcCtD
Ibandronate—Hypertension—Betamethasone—multiple sclerosis	0.000777	0.000777	CcSEcCtD
Ibandronate—Hypertension—Dexamethasone—multiple sclerosis	0.000777	0.000777	CcSEcCtD
Ibandronate—Asthenia—Mitoxantrone—multiple sclerosis	0.00077	0.00077	CcSEcCtD
Ibandronate—Myalgia—Dexamethasone—multiple sclerosis	0.000766	0.000766	CcSEcCtD
Ibandronate—Myalgia—Betamethasone—multiple sclerosis	0.000766	0.000766	CcSEcCtD
Ibandronate—Anxiety—Betamethasone—multiple sclerosis	0.000764	0.000764	CcSEcCtD
Ibandronate—Anxiety—Dexamethasone—multiple sclerosis	0.000764	0.000764	CcSEcCtD
Ibandronate—Discomfort—Betamethasone—multiple sclerosis	0.000757	0.000757	CcSEcCtD
Ibandronate—Discomfort—Dexamethasone—multiple sclerosis	0.000757	0.000757	CcSEcCtD
Ibandronate—Haemoglobin—Methotrexate—multiple sclerosis	0.000756	0.000756	CcSEcCtD
Ibandronate—Pain—Prednisolone—multiple sclerosis	0.000753	0.000753	CcSEcCtD
Ibandronate—Haemorrhage—Methotrexate—multiple sclerosis	0.000752	0.000752	CcSEcCtD
Ibandronate—Pharyngitis—Methotrexate—multiple sclerosis	0.000747	0.000747	CcSEcCtD
Ibandronate—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000743	0.000743	CcSEcCtD
Ibandronate—Urethral disorder—Methotrexate—multiple sclerosis	0.000738	0.000738	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000737	0.000737	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000736	0.000736	CcSEcCtD
Ibandronate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000734	0.000734	CcSEcCtD
Ibandronate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000734	0.000734	CcSEcCtD
Ibandronate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000734	0.000734	CcSEcCtD
Ibandronate—Insomnia—Triamcinolone—multiple sclerosis	0.000732	0.000732	CcSEcCtD
Ibandronate—Insomnia—Methylprednisolone—multiple sclerosis	0.00073	0.00073	CcSEcCtD
Ibandronate—Infection—Dexamethasone—multiple sclerosis	0.00073	0.00073	CcSEcCtD
Ibandronate—Infection—Betamethasone—multiple sclerosis	0.00073	0.00073	CcSEcCtD
Ibandronate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000727	0.000727	CcSEcCtD
Ibandronate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000727	0.000727	CcSEcCtD
Ibandronate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000725	0.000725	CcSEcCtD
Ibandronate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000725	0.000725	CcSEcCtD
Ibandronate—Anaemia—Prednisone—multiple sclerosis	0.000724	0.000724	CcSEcCtD
Ibandronate—Shock—Dexamethasone—multiple sclerosis	0.000723	0.000723	CcSEcCtD
Ibandronate—Shock—Betamethasone—multiple sclerosis	0.000723	0.000723	CcSEcCtD
Ibandronate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00072	0.00072	CcSEcCtD
Ibandronate—Nervous system disorder—Betamethasone—multiple sclerosis	0.00072	0.00072	CcSEcCtD
Ibandronate—Angioedema—Prednisone—multiple sclerosis	0.000716	0.000716	CcSEcCtD
Ibandronate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000713	0.000713	CcSEcCtD
Ibandronate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000711	0.000711	CcSEcCtD
Ibandronate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00071	0.00071	CcSEcCtD
Ibandronate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00071	0.00071	CcSEcCtD
Ibandronate—Malaise—Prednisone—multiple sclerosis	0.000707	0.000707	CcSEcCtD
Ibandronate—Vertigo—Prednisone—multiple sclerosis	0.000704	0.000704	CcSEcCtD
Ibandronate—Eye disorder—Methotrexate—multiple sclerosis	0.000703	0.000703	CcSEcCtD
Ibandronate—Urticaria—Prednisolone—multiple sclerosis	0.000699	0.000699	CcSEcCtD
Ibandronate—Cardiac disorder—Methotrexate—multiple sclerosis	0.000698	0.000698	CcSEcCtD
Ibandronate—Fatigue—Triamcinolone—multiple sclerosis	0.000698	0.000698	CcSEcCtD
Ibandronate—Fatigue—Methylprednisolone—multiple sclerosis	0.000696	0.000696	CcSEcCtD
Ibandronate—Pain—Triamcinolone—multiple sclerosis	0.000692	0.000692	CcSEcCtD
Ibandronate—Angiopathy—Methotrexate—multiple sclerosis	0.000683	0.000683	CcSEcCtD
Ibandronate—Vomiting—Mitoxantrone—multiple sclerosis	0.000682	0.000682	CcSEcCtD
Ibandronate—Immune system disorder—Methotrexate—multiple sclerosis	0.00068	0.00068	CcSEcCtD
Ibandronate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000678	0.000678	CcSEcCtD
Ibandronate—Hypertension—Prednisone—multiple sclerosis	0.000677	0.000677	CcSEcCtD
Ibandronate—Rash—Mitoxantrone—multiple sclerosis	0.000676	0.000676	CcSEcCtD
Ibandronate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000676	0.000676	CcSEcCtD
Ibandronate—Chills—Methotrexate—multiple sclerosis	0.000675	0.000675	CcSEcCtD
Ibandronate—Headache—Mitoxantrone—multiple sclerosis	0.000672	0.000672	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000669	0.000669	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000669	0.000669	CcSEcCtD
Ibandronate—Arthralgia—Prednisone—multiple sclerosis	0.000667	0.000667	CcSEcCtD
Ibandronate—Myalgia—Prednisone—multiple sclerosis	0.000667	0.000667	CcSEcCtD
Ibandronate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000667	0.000667	CcSEcCtD
Ibandronate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000666	0.000666	CcSEcCtD
Ibandronate—Anxiety—Prednisone—multiple sclerosis	0.000665	0.000665	CcSEcCtD
Ibandronate—Alopecia—Methotrexate—multiple sclerosis	0.000665	0.000665	CcSEcCtD
Ibandronate—Insomnia—Dexamethasone—multiple sclerosis	0.000664	0.000664	CcSEcCtD
Ibandronate—Insomnia—Betamethasone—multiple sclerosis	0.000664	0.000664	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000663	0.000663	CcSEcCtD
Ibandronate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00066	0.00066	CcSEcCtD
Ibandronate—Paraesthesia—Dexamethasone—multiple sclerosis	0.00066	0.00066	CcSEcCtD
Ibandronate—Paraesthesia—Betamethasone—multiple sclerosis	0.00066	0.00066	CcSEcCtD
Ibandronate—Discomfort—Prednisone—multiple sclerosis	0.000659	0.000659	CcSEcCtD
Ibandronate—Mental disorder—Methotrexate—multiple sclerosis	0.000659	0.000659	CcSEcCtD
Ibandronate—Malnutrition—Methotrexate—multiple sclerosis	0.000655	0.000655	CcSEcCtD
Ibandronate—Erythema—Methotrexate—multiple sclerosis	0.000655	0.000655	CcSEcCtD
Ibandronate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000649	0.000649	CcSEcCtD
Ibandronate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000647	0.000647	CcSEcCtD
Ibandronate—Dyspepsia—Betamethasone—multiple sclerosis	0.000647	0.000647	CcSEcCtD
Ibandronate—Urticaria—Triamcinolone—multiple sclerosis	0.000643	0.000643	CcSEcCtD
Ibandronate—Urticaria—Methylprednisolone—multiple sclerosis	0.000642	0.000642	CcSEcCtD
Ibandronate—Dysgeusia—Methotrexate—multiple sclerosis	0.000641	0.000641	CcSEcCtD
Ibandronate—Body temperature increased—Triamcinolone—multiple sclerosis	0.00064	0.00064	CcSEcCtD
Ibandronate—Anaphylactic shock—Prednisone—multiple sclerosis	0.00064	0.00064	CcSEcCtD
Ibandronate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000638	0.000638	CcSEcCtD
Ibandronate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000638	0.000638	CcSEcCtD
Ibandronate—Decreased appetite—Betamethasone—multiple sclerosis	0.000638	0.000638	CcSEcCtD
Ibandronate—Nausea—Mitoxantrone—multiple sclerosis	0.000637	0.000637	CcSEcCtD
Ibandronate—Infection—Prednisone—multiple sclerosis	0.000635	0.000635	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000634	0.000634	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000634	0.000634	CcSEcCtD
Ibandronate—Back pain—Methotrexate—multiple sclerosis	0.000634	0.000634	CcSEcCtD
Ibandronate—Fatigue—Betamethasone—multiple sclerosis	0.000633	0.000633	CcSEcCtD
Ibandronate—Fatigue—Dexamethasone—multiple sclerosis	0.000633	0.000633	CcSEcCtD
Ibandronate—Shock—Prednisone—multiple sclerosis	0.000629	0.000629	CcSEcCtD
Ibandronate—Pain—Betamethasone—multiple sclerosis	0.000628	0.000628	CcSEcCtD
Ibandronate—Pain—Dexamethasone—multiple sclerosis	0.000628	0.000628	CcSEcCtD
Ibandronate—Nervous system disorder—Prednisone—multiple sclerosis	0.000627	0.000627	CcSEcCtD
Ibandronate—Skin disorder—Prednisone—multiple sclerosis	0.000621	0.000621	CcSEcCtD
Ibandronate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000618	0.000618	CcSEcCtD
Ibandronate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000608	0.000608	CcSEcCtD
Ibandronate—Anaemia—Methotrexate—multiple sclerosis	0.000605	0.000605	CcSEcCtD
Ibandronate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000605	0.000605	CcSEcCtD
Ibandronate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000605	0.000605	CcSEcCtD
Ibandronate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000601	0.000601	CcSEcCtD
Ibandronate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000601	0.000601	CcSEcCtD
Ibandronate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000596	0.000596	CcSEcCtD
Ibandronate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000595	0.000595	CcSEcCtD
Ibandronate—Malaise—Methotrexate—multiple sclerosis	0.000591	0.000591	CcSEcCtD
Ibandronate—Vertigo—Methotrexate—multiple sclerosis	0.000588	0.000588	CcSEcCtD
Ibandronate—Urticaria—Dexamethasone—multiple sclerosis	0.000583	0.000583	CcSEcCtD
Ibandronate—Urticaria—Betamethasone—multiple sclerosis	0.000583	0.000583	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000583	0.000583	CcSEcCtD
Ibandronate—Dizziness—Prednisolone—multiple sclerosis	0.000582	0.000582	CcSEcCtD
Ibandronate—Asthenia—Triamcinolone—multiple sclerosis	0.000581	0.000581	CcSEcCtD
Ibandronate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000581	0.000581	CcSEcCtD
Ibandronate—Body temperature increased—Betamethasone—multiple sclerosis	0.000581	0.000581	CcSEcCtD
Ibandronate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000581	0.000581	CcSEcCtD
Ibandronate—Abdominal pain—Betamethasone—multiple sclerosis	0.000581	0.000581	CcSEcCtD
Ibandronate—Asthenia—Methylprednisolone—multiple sclerosis	0.000579	0.000579	CcSEcCtD
Ibandronate—Insomnia—Prednisone—multiple sclerosis	0.000579	0.000579	CcSEcCtD
Ibandronate—Paraesthesia—Prednisone—multiple sclerosis	0.000574	0.000574	CcSEcCtD
Ibandronate—Pruritus—Triamcinolone—multiple sclerosis	0.000573	0.000573	CcSEcCtD
Ibandronate—Pruritus—Methylprednisolone—multiple sclerosis	0.000571	0.000571	CcSEcCtD
Ibandronate—Dyspepsia—Prednisone—multiple sclerosis	0.000563	0.000563	CcSEcCtD
Ibandronate—Chest pain—Methotrexate—multiple sclerosis	0.000558	0.000558	CcSEcCtD
Ibandronate—Arthralgia—Methotrexate—multiple sclerosis	0.000558	0.000558	CcSEcCtD
Ibandronate—Myalgia—Methotrexate—multiple sclerosis	0.000558	0.000558	CcSEcCtD
Ibandronate—Decreased appetite—Prednisone—multiple sclerosis	0.000556	0.000556	CcSEcCtD
Ibandronate—Rash—Prednisolone—multiple sclerosis	0.000555	0.000555	CcSEcCtD
Ibandronate—Dermatitis—Prednisolone—multiple sclerosis	0.000554	0.000554	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000554	0.000554	CcSEcCtD
Ibandronate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000553	0.000553	CcSEcCtD
Ibandronate—Fatigue—Prednisone—multiple sclerosis	0.000551	0.000551	CcSEcCtD
Ibandronate—Headache—Prednisolone—multiple sclerosis	0.000551	0.000551	CcSEcCtD
Ibandronate—Discomfort—Methotrexate—multiple sclerosis	0.000551	0.000551	CcSEcCtD
Ibandronate—Constipation—Prednisone—multiple sclerosis	0.000547	0.000547	CcSEcCtD
Ibandronate—Dizziness—Triamcinolone—multiple sclerosis	0.000535	0.000535	CcSEcCtD
Ibandronate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000535	0.000535	CcSEcCtD
Ibandronate—Dizziness—Methylprednisolone—multiple sclerosis	0.000534	0.000534	CcSEcCtD
Ibandronate—Infection—Methotrexate—multiple sclerosis	0.000531	0.000531	CcSEcCtD
Ibandronate—Feeling abnormal—Prednisone—multiple sclerosis	0.000527	0.000527	CcSEcCtD
Ibandronate—Asthenia—Dexamethasone—multiple sclerosis	0.000527	0.000527	CcSEcCtD
Ibandronate—Asthenia—Betamethasone—multiple sclerosis	0.000527	0.000527	CcSEcCtD
Ibandronate—Nervous system disorder—Methotrexate—multiple sclerosis	0.000524	0.000524	CcSEcCtD
Ibandronate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000523	0.000523	CcSEcCtD
Ibandronate—Nausea—Prednisolone—multiple sclerosis	0.000523	0.000523	CcSEcCtD
Ibandronate—Pruritus—Betamethasone—multiple sclerosis	0.00052	0.00052	CcSEcCtD
Ibandronate—Pruritus—Dexamethasone—multiple sclerosis	0.00052	0.00052	CcSEcCtD
Ibandronate—Skin disorder—Methotrexate—multiple sclerosis	0.000519	0.000519	CcSEcCtD
Ibandronate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000517	0.000517	CcSEcCtD
Ibandronate—Vomiting—Triamcinolone—multiple sclerosis	0.000515	0.000515	CcSEcCtD
Ibandronate—Vomiting—Methylprednisolone—multiple sclerosis	0.000514	0.000514	CcSEcCtD
Ibandronate—Rash—Triamcinolone—multiple sclerosis	0.00051	0.00051	CcSEcCtD
Ibandronate—Dermatitis—Triamcinolone—multiple sclerosis	0.00051	0.00051	CcSEcCtD
Ibandronate—Rash—Methylprednisolone—multiple sclerosis	0.000509	0.000509	CcSEcCtD
Ibandronate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000509	0.000509	CcSEcCtD
Ibandronate—Urticaria—Prednisone—multiple sclerosis	0.000508	0.000508	CcSEcCtD
Ibandronate—Headache—Triamcinolone—multiple sclerosis	0.000507	0.000507	CcSEcCtD
Ibandronate—Headache—Methylprednisolone—multiple sclerosis	0.000506	0.000506	CcSEcCtD
Ibandronate—Body temperature increased—Prednisone—multiple sclerosis	0.000506	0.000506	CcSEcCtD
Ibandronate—Abdominal pain—Prednisone—multiple sclerosis	0.000506	0.000506	CcSEcCtD
Ibandronate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000503	0.000503	CcSEcCtD
Ibandronate—Diarrhoea—Betamethasone—multiple sclerosis	0.000503	0.000503	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000487	0.000487	CcSEcCtD
Ibandronate—Dizziness—Dexamethasone—multiple sclerosis	0.000486	0.000486	CcSEcCtD
Ibandronate—Dizziness—Betamethasone—multiple sclerosis	0.000486	0.000486	CcSEcCtD
Ibandronate—Insomnia—Methotrexate—multiple sclerosis	0.000483	0.000483	CcSEcCtD
Ibandronate—Nausea—Triamcinolone—multiple sclerosis	0.000481	0.000481	CcSEcCtD
Ibandronate—Paraesthesia—Methotrexate—multiple sclerosis	0.00048	0.00048	CcSEcCtD
Ibandronate—Nausea—Methylprednisolone—multiple sclerosis	0.00048	0.00048	CcSEcCtD
Ibandronate—Hypersensitivity—Prednisone—multiple sclerosis	0.000471	0.000471	CcSEcCtD
Ibandronate—Dyspepsia—Methotrexate—multiple sclerosis	0.000471	0.000471	CcSEcCtD
Ibandronate—Vomiting—Dexamethasone—multiple sclerosis	0.000467	0.000467	CcSEcCtD
Ibandronate—Vomiting—Betamethasone—multiple sclerosis	0.000467	0.000467	CcSEcCtD
Ibandronate—Decreased appetite—Methotrexate—multiple sclerosis	0.000465	0.000465	CcSEcCtD
Ibandronate—Rash—Dexamethasone—multiple sclerosis	0.000463	0.000463	CcSEcCtD
Ibandronate—Rash—Betamethasone—multiple sclerosis	0.000463	0.000463	CcSEcCtD
Ibandronate—Dermatitis—Betamethasone—multiple sclerosis	0.000463	0.000463	CcSEcCtD
Ibandronate—Dermatitis—Dexamethasone—multiple sclerosis	0.000463	0.000463	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000462	0.000462	CcSEcCtD
Ibandronate—Fatigue—Methotrexate—multiple sclerosis	0.000461	0.000461	CcSEcCtD
Ibandronate—Headache—Dexamethasone—multiple sclerosis	0.00046	0.00046	CcSEcCtD
Ibandronate—Headache—Betamethasone—multiple sclerosis	0.00046	0.00046	CcSEcCtD
Ibandronate—Asthenia—Prednisone—multiple sclerosis	0.000459	0.000459	CcSEcCtD
Ibandronate—Pain—Methotrexate—multiple sclerosis	0.000457	0.000457	CcSEcCtD
Ibandronate—Pruritus—Prednisone—multiple sclerosis	0.000453	0.000453	CcSEcCtD
Ibandronate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000441	0.000441	CcSEcCtD
Ibandronate—Diarrhoea—Prednisone—multiple sclerosis	0.000438	0.000438	CcSEcCtD
Ibandronate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000437	0.000437	CcSEcCtD
Ibandronate—Nausea—Betamethasone—multiple sclerosis	0.000436	0.000436	CcSEcCtD
Ibandronate—Nausea—Dexamethasone—multiple sclerosis	0.000436	0.000436	CcSEcCtD
Ibandronate—Urticaria—Methotrexate—multiple sclerosis	0.000425	0.000425	CcSEcCtD
Ibandronate—Dizziness—Prednisone—multiple sclerosis	0.000423	0.000423	CcSEcCtD
Ibandronate—Body temperature increased—Methotrexate—multiple sclerosis	0.000423	0.000423	CcSEcCtD
Ibandronate—Abdominal pain—Methotrexate—multiple sclerosis	0.000423	0.000423	CcSEcCtD
Ibandronate—Vomiting—Prednisone—multiple sclerosis	0.000407	0.000407	CcSEcCtD
Ibandronate—Rash—Prednisone—multiple sclerosis	0.000403	0.000403	CcSEcCtD
Ibandronate—Dermatitis—Prednisone—multiple sclerosis	0.000403	0.000403	CcSEcCtD
Ibandronate—Headache—Prednisone—multiple sclerosis	0.000401	0.000401	CcSEcCtD
Ibandronate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000394	0.000394	CcSEcCtD
Ibandronate—Asthenia—Methotrexate—multiple sclerosis	0.000384	0.000384	CcSEcCtD
Ibandronate—Nausea—Prednisone—multiple sclerosis	0.00038	0.00038	CcSEcCtD
Ibandronate—Pruritus—Methotrexate—multiple sclerosis	0.000378	0.000378	CcSEcCtD
Ibandronate—Diarrhoea—Methotrexate—multiple sclerosis	0.000366	0.000366	CcSEcCtD
Ibandronate—Dizziness—Methotrexate—multiple sclerosis	0.000353	0.000353	CcSEcCtD
Ibandronate—Vomiting—Methotrexate—multiple sclerosis	0.00034	0.00034	CcSEcCtD
Ibandronate—Rash—Methotrexate—multiple sclerosis	0.000337	0.000337	CcSEcCtD
Ibandronate—Dermatitis—Methotrexate—multiple sclerosis	0.000337	0.000337	CcSEcCtD
Ibandronate—Headache—Methotrexate—multiple sclerosis	0.000335	0.000335	CcSEcCtD
Ibandronate—Nausea—Methotrexate—multiple sclerosis	0.000318	0.000318	CcSEcCtD
